Service utilization and expenditures for the treatment of panic disorder. (Q47799395)

5 February 2018

title

Service utilization and expenditures for the treatment of panic disorder. (English)

1 reference

5 February 2018

author name string

Leon AC

series ordinal

1

1 reference

5 February 2018

Olfson M

series ordinal

2

1 reference

5 February 2018

Portera L

series ordinal

3

1 reference

5 February 2018

publication date

1 March 1997

1 reference

5 February 2018

General Hospital Psychiatry

published in

1 reference

5 February 2018

volume

19

1 reference

5 February 2018

page(s)

82-88

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Quality of life in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Suicidal ideation and suicide attempts in panic disorder and attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Panic disorder, comorbidity, and suicide attempts.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Panic attacks in the community. Social morbidity and health care utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Evaluating the diagnostic criteria for panic disorder: measures of social morbidity as criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Panic disorder: Relationship to high medical utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Factors affecting the utilization of specialty and general medical mental health services.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Societal and individual determinants of medical care utilization in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

The hidden mental health network. Treatment of mental illness by nonpsychiatrist physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Treating depression in primary care practice. An application of decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Overview of the Cross-National Collaborative Panic Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Assessing impairment in patients with panic disorder: the Sheehan Disability Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Development and validation of the SDDS-PC screen for multiple mental disorders in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Brief diagnostic interviews (SDDS-PC) for multiple mental disorders in primary care. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Brief screens for mental disorders in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

A comparison of alprazolam and behavior therapy in treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2896%2900154-5

7 January 2021

10.1016/S0163-8343(96)00154-5

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9097062

1 reference

5 February 2018